Women’s Participation in Pap Smear Screening in a Developing Country: Evidence for Improving Health Systems

IntroductionEvery year about 83,000 women are diagnosed with cervical cancer in the Americas. Latin America and the Caribbean (LAC) has one of the highest incidence and mortality rates from cervical cancer in the world. Although incidence has decreased by half in the last 30 years, cervical cancer r...

Full description

Bibliographic Details
Main Authors: Carolina Santamaría-Ulloa, Ileana Quirós-Rojas, Melina Montero-López, Hazel Quesada-Leitón
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.642841/full
_version_ 1818872397122502656
author Carolina Santamaría-Ulloa
Ileana Quirós-Rojas
Melina Montero-López
Hazel Quesada-Leitón
author_facet Carolina Santamaría-Ulloa
Ileana Quirós-Rojas
Melina Montero-López
Hazel Quesada-Leitón
author_sort Carolina Santamaría-Ulloa
collection DOAJ
description IntroductionEvery year about 83,000 women are diagnosed with cervical cancer in the Americas. Latin America and the Caribbean (LAC) has one of the highest incidence and mortality rates from cervical cancer in the world. Although incidence has decreased by half in the last 30 years, cervical cancer remains a public health concern. The detection of precursor lesions through Papanicolaou (Pap) smear remains a critical tool in the context of prevention in Costa Rica and many other LAC countries.ObjectiveTo determine predictors of participation in Pap smear screening among Costa Rican women, with a special focus on women who have never had a Pap smear or have had a smear 5 or more years ago.MethodsThe data source for this study is the Costa Rican Households National Survey conducted in 2014. This survey is representative at the national, urban/rural zone, and administrative region level. A subsample of women aged 20 to 69 years who responded to the survey’s Papanicolaou Module were included in this study (n = 11,709). Statistical analyses were conducted in R-Studio. Statistical significance level was set at 5%. Two multinomial regression models were estimated. The first model aimed to explain the five different categories of cytology use, which were defined according to the last time women had a Pap smear. The second model aimed to explain the five different categories of reasons why women had never had a Pap smear. Both models controlled for age, educational attainment, and marital status.ResultsYoung women with high educational attainment were more likely to have never had a cytology. Women with a lower educational attainment, married, or in domestic relationship and of older age had greater odds of having had a cytology 5 or more years ago. Each year increment in age was significantly associated with an increase in the odds of never having a Pap smear because of health care access issues or because of cultural reasons as compared to not having an active sexual life.ConclusionsFindings can inform public policy targeted to higher risk female populations where access to health services can be improved.
first_indexed 2024-12-19T12:38:09Z
format Article
id doaj.art-69f4f905577c44868d8b2e5caa682a06
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-12-19T12:38:09Z
publishDate 2021-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-69f4f905577c44868d8b2e5caa682a062022-12-21T20:21:04ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2021-06-011110.3389/fonc.2021.642841642841Women’s Participation in Pap Smear Screening in a Developing Country: Evidence for Improving Health SystemsCarolina Santamaría-Ulloa0Ileana Quirós-Rojas1Melina Montero-López2Hazel Quesada-Leitón3Instituto de Investigaciones en Salud, Universidad de Costa Rica, San Jose, Costa RicaCoordinacion Tecnica del Cancer, Caja Costarricense del Seguro Social, San Jose, Costa RicaInstituto de Investigaciones en Salud, Universidad de Costa Rica, San Jose, Costa RicaEscuela de Estadística, Universidad de Costa Rica, San Jose, Costa RicaIntroductionEvery year about 83,000 women are diagnosed with cervical cancer in the Americas. Latin America and the Caribbean (LAC) has one of the highest incidence and mortality rates from cervical cancer in the world. Although incidence has decreased by half in the last 30 years, cervical cancer remains a public health concern. The detection of precursor lesions through Papanicolaou (Pap) smear remains a critical tool in the context of prevention in Costa Rica and many other LAC countries.ObjectiveTo determine predictors of participation in Pap smear screening among Costa Rican women, with a special focus on women who have never had a Pap smear or have had a smear 5 or more years ago.MethodsThe data source for this study is the Costa Rican Households National Survey conducted in 2014. This survey is representative at the national, urban/rural zone, and administrative region level. A subsample of women aged 20 to 69 years who responded to the survey’s Papanicolaou Module were included in this study (n = 11,709). Statistical analyses were conducted in R-Studio. Statistical significance level was set at 5%. Two multinomial regression models were estimated. The first model aimed to explain the five different categories of cytology use, which were defined according to the last time women had a Pap smear. The second model aimed to explain the five different categories of reasons why women had never had a Pap smear. Both models controlled for age, educational attainment, and marital status.ResultsYoung women with high educational attainment were more likely to have never had a cytology. Women with a lower educational attainment, married, or in domestic relationship and of older age had greater odds of having had a cytology 5 or more years ago. Each year increment in age was significantly associated with an increase in the odds of never having a Pap smear because of health care access issues or because of cultural reasons as compared to not having an active sexual life.ConclusionsFindings can inform public policy targeted to higher risk female populations where access to health services can be improved.https://www.frontiersin.org/articles/10.3389/fonc.2021.642841/fullPapanicolaoupreventioncervical cancerscreeningwomen’s health
spellingShingle Carolina Santamaría-Ulloa
Ileana Quirós-Rojas
Melina Montero-López
Hazel Quesada-Leitón
Women’s Participation in Pap Smear Screening in a Developing Country: Evidence for Improving Health Systems
Frontiers in Oncology
Papanicolaou
prevention
cervical cancer
screening
women’s health
title Women’s Participation in Pap Smear Screening in a Developing Country: Evidence for Improving Health Systems
title_full Women’s Participation in Pap Smear Screening in a Developing Country: Evidence for Improving Health Systems
title_fullStr Women’s Participation in Pap Smear Screening in a Developing Country: Evidence for Improving Health Systems
title_full_unstemmed Women’s Participation in Pap Smear Screening in a Developing Country: Evidence for Improving Health Systems
title_short Women’s Participation in Pap Smear Screening in a Developing Country: Evidence for Improving Health Systems
title_sort women s participation in pap smear screening in a developing country evidence for improving health systems
topic Papanicolaou
prevention
cervical cancer
screening
women’s health
url https://www.frontiersin.org/articles/10.3389/fonc.2021.642841/full
work_keys_str_mv AT carolinasantamariaulloa womensparticipationinpapsmearscreeninginadevelopingcountryevidenceforimprovinghealthsystems
AT ileanaquirosrojas womensparticipationinpapsmearscreeninginadevelopingcountryevidenceforimprovinghealthsystems
AT melinamonterolopez womensparticipationinpapsmearscreeninginadevelopingcountryevidenceforimprovinghealthsystems
AT hazelquesadaleiton womensparticipationinpapsmearscreeninginadevelopingcountryevidenceforimprovinghealthsystems